Self-Disclosure for Grant Recipients: New OIG Guidance
Weighing the Risks and Rewards of Self-Reporting

Welcome! Strafford is now BARBRI! The expert courses you know from the trusted global leader in legal education.
Course Details
- smart_display Format
On-Demand
- signal_cellular_alt Difficulty Level
- work Practice Area
Health
- event Date
Thursday, November 7, 2019
- schedule Time
1:00 PM E.T.
- timer Program Length
90 minutes
-
This 90-minute webinar is eligible in most states for 1.5 CLE credits.
-
Live Online
On Demand
This CLE course will guide counsel for academic medical centers, universities and other federal grant recipients on the Office of Inspector General's (OIG) self-disclosure protocol and its new guidance for HHS grant recipients. The panel will provide best practices for self-disclosure and compliance.
Faculty

Ms. Bonham is skilled healthcare attorney and nationally recognized expert in research compliance, government and internal investigations, integrity, and bioethics. She has nearly 20 years of experience in the U.S. Department of Health and Human Services as a leader in healthcare, life sciences, enforcement and public policy. Ms. Bonham served as a senior advisor in the Office of the Director of the National Institutes of Health and as a senior attorney in the Office of the General Counsel of the HHS.

Ms. Mayer advises industry-leading healthcare and life science companies in criminal, civil and regulatory enforcement matters and in related complex civil litigation, including civil False Claims Act litigation. In addition to defending clients in litigation, she advises clients with respect to fraud and abuse and compliance in several contexts, including Corporate Integrity Agreement implementation, internal investigations, and strategic transactions in the healthcare industry.a
Description
In June 2019, the Department of Health and Human Service’ Office of Inspector General (OIG) issued important new guidance on mandatory and voluntary self-disclosures in connection with all DHHS grants, including research awards from NIH, HRSA, and other components and operating divisions. HHS grant recipients and subrecipients are expected to disclose evidence of potential violations of criminal fraud, bribery, or gratuity laws and are encouraged to voluntarily disclose other conduct that might violate civil or administrative laws. The new guidance alerts grant recipients to HHS’s current views on when and how self- disclosures should be made.
Those who receive federal research dollars, including academic medical centers, universities, and small businesses, as well as their subawardees and collaborators, face significant and increasing regulatory oversight and scrutiny. While the OIG has had authority over grantees and subawardees for some time, changes in the 21st Century Cures Act strengthened and emphasized its central role in redressing certain types of grant compliance concerns. The conduct for which self-disclosure may be appropriate ranges from inappropriate cost reporting to false claims.
Grant recipients and subawardees can face high financial penalties as well as exclusion from federal healthcare programs. For investigators, academic medical centers, universities, and others, exclusion, for even temporary time periods, can be disastrous. Federal grant recipients and their counsel must understand the types of violations for which these sanctions may be imposed and as well as the tools for resolving grant compliance concerns, including self-disclosure.
Listen as our authoritative panel of healthcare counsel examines the OIG self-disclosure protocol and the new guidance, and what both mean for HHS grant and federal research recipients and subawardees. The panel will offer best practices for self-disclosure and compliance.
Outline
- OIG's Self-Disclosure Protocol
- New OIG guidance for HHS grant recipients
- Best practices for self-disclosure
- When to disclose and to whom
- Alternatives to self-disclosure
- Potential risks of making a self-disclosure
- Preserving privileged communications
Benefits
The panel will review these and other key issues:
- How has the new guidance on self-disclosure altered the playing field for HHS grant recipients?
- What factors should academic medical centers, universities, and other federal grant recipients consider when determining whether and when to disclose a potential Stark law or AKS violation?
- What are the best practices for academic medical centers, universities, and other federal grant recipients and their counsel when preparing the disclosure submission?
Unlimited access to premium CLE courses:
- Annual access
- Available live and on-demand
- Best for attorneys and legal professionals
Unlimited access to premium CPE courses.:
- Annual access
- Available live and on-demand
- Best for CPAs and tax professionals
Unlimited access to premium CLE, CPE, Professional Skills and Practice-Ready courses.:
- Annual access
- Available live and on-demand
- Best for legal, accounting, and tax professionals
Unlimited access to Professional Skills and Practice-Ready courses:
- Annual access
- Available on-demand
- Best for new attorneys
Related Courses

Healthcare Board of Directors: Meeting Governance and Compliance Challenges
Available On-Demand

DEA Prescription Audits and Investigations: Triggering Events; Process Navigation; Mitigating Noncompliance Risks
Wednesday, November 5, 2025
1:00 p.m. ET./10:00 a.m. PT

HIPAA and Data Privacy Compliance in Healthcare Litigation
Wednesday, October 8, 2025
1:00 p.m. ET./10:00 a.m. PT

Government Permit Issues in Healthcare M&A Transactions: Buyer and Seller Strategies, Compliance Challenges
Wednesday, October 22, 2025
1:00 p.m. ET./10:00 a.m. PT
Recommended Resources
Navigating Modern Legal Challenges: A Comprehensive Guide
- Business & Professional Skills
- Career Advancement